Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Net Income (2023 - 2026)

Guardian Pharmacy Services recorded quarterly Net Income of $13.5 million in Q1 2026, down 36.31% quarter-over-quarter from $21.3 million in Q4 2025, and up 46.06% year-over-year from $9.3 million in Q1 2025.

Guardian Pharmacy Services' Net Income history runs 4 years deep, the most recent figure standing at $13.5 million for Q1 2026.

  • In Q1 2026, Net Income rose 46.06% year-over-year to $13.5 million; the TTM figure through Mar 2026 stood at $53.2 million (up 177.31% YoY), while the FY2025 annual figure was $49.0 million, up 168.92% from the prior year.
  • Net Income came in at $13.5 million for Q1 2026 at Guardian Pharmacy Services, down from $21.3 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $21.3 million in Q4 2025 to a low of -$105.8 million in Q3 2024.
  • A 4-year average of -$87909.1 and a median of $9.6 million in 2025 frame the typical range for Net Income.
  • Across the five-year window, Net Income plunged 1412.75% in 2024 and jumped 109.07% in 2025, its largest moves.
  • Guardian Pharmacy Services' Net Income stood at $14.6 million in 2023, then fell by 18.67% to $11.8 million in 2024, then surged by 79.59% to $21.3 million in 2025, then slumped by 36.31% to $13.5 million in 2026.
  • According to Business Quant data, Net Income over the past three periods registered $13.5 million, $21.3 million, and $9.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn 1.86 Bn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn 906.00 Mn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn 275.04 Mn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn 15.90 Mn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn 99.76 Mn
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn 358.68 Mn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn 68.68 Mn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn 66.30 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn 80.67 Mn
10 Guardian Pharmacy Services 2.45 Mn -50.91 Mn 76.31 Mn 13.54 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 13.54 Mn
Dec 31, 2025 21.27 Mn
Sep 30, 2025 9.59 Mn
Jun 30, 2025 8.83 Mn
Mar 31, 2025 9.27 Mn
Dec 31, 2024 11.84 Mn
Sep 30, 2024 -105.82 Mn
Jun 30, 2024 15.85 Mn
Mar 31, 2024 7.10 Mn
Dec 31, 2023 14.56 Mn
Sep 30, 2023 -7.00 Mn